Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The trigeminocervical complex (TCC) is a functional region located in the dorsal horns of the medulla and upper cervical spinal cord (C1–C3). It acts as a key relay site for the convergence of sensory afferents from the cranial (trigeminal) and cervical nerves. Lamina I neurons within this region integrate nociceptive input from both the head (via trigeminal nerve) and neck (via upper cervical nerves), which is then relayed to higher centers in the thalamus and cortex. The TCC is critically involved in the pathogenesis of primary headaches (including migraine), the mechanism of referred craniofacial pain, and the central modulation of cervico-cranial nociception. Drug therapies for migraine—including triptans, CGRP antagonists, NSAIDs, and some nerve blocks—exert their effects in part by modulating neural activity within this complex region
Inhibition of nociceptive transmission within the trigeminocervical complex (central mechanisms)\nActivation or modulation of serotonergic and CGRP pathways affecting TCC neurons\nPeripheral nerve blockade modulating TCC input (e.g., greater occipital nerve anesthesia)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminocervical complex (TCC).